Could the Trade War Truce With China Help Stem the Opioid Crisis?

President Xi agrees to designate fentanyl as a controlled substance.

President Donald Trump with China's President Xi Jinping during their bilateral meeting at the G-20 Summit on SaturdayAP Photo/Pablo Martinez Monsivais

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

Meeting with President Donald Trump at the G-20 summit on Saturday in Buenos Aires, President Xi Jinping of China agreed to classify the powerful opioid fentanyl as a controlled substance, a concession long sought by the Trump administration as a way to curb the overdose epidemic afflicting the United States.

The agreement was struck over a steak dinner as part of a broader discussion about the countries’ trade and foreign policy. China is the world’s biggest producer of illicit fentanyl, an opioid up to 100 times more powerful than morphine that kills tens of thousands of Americans every year.

In a statement, the White House described Xi’s pledge on fentanyl as “a wonderful humanitarian gesture” that would ensure people selling the drug to the United States would “be subject to China’s maximum penalty under the law.” Most fentanyl in the United States is illegally manufactured in China and sent here in the mail, sometimes by way of Mexico, where it is mixed with other drugs. In August, Trump blasted China on Twitter for fueling America’s overdose crisis.

Speaking with reporters aboard Air Force One after the meeting, Trump “seemed most excited” about the opioid aspect of the latest trade negotiations, according to NPR White House correspondent Tamara Keith. The broader deal included the United States promising to hold off on new tariffs that were supposed to go into effect on January 1 on $200 billion worth of products, while China pledged to boost its purchases of American products, including agricultural goods. The two sides agreed on a 90-day deadline to reach an agreement on other aspects of the trade deal, according to a White House statement.

“The relationship is very special—the relationship that I have with President Xi,” Trump told reporters during the dinner with Xi, who for his part said, “Only with cooperation between us can we serve the interest of world peace and prosperity.”

China’s classification of fentanyl as a controlled substance comes after Trump signed legislation in January that gave Customs and Border Protection $9 million for machines that could scan and detect fentanyl in the mail without requiring agents to open packages. In October, he signed another bill that seeks to expand access to treatment.

But as Mother Jones‘ Julia Lurie has reported, “while the bill outlines a number of far-reaching goals, drug policy experts say Congress hasn’t allocated nearly enough money to execute them well.” And the president’s tough talk on opioids has not been matched by much substantive reform. Meanwhile, his administration has pushed to impose work requirements for recipients of Medicaid, the country’s biggest provider of insurance for people struggling with addiction.

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate